Clinical trials
Recruiting Invasive Fungal Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2012 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 1 |
| Biosergen AS | 1 |
| International Centre for Diarrhoeal Disease Research, Bangladesh | 1 |
| Melbourne Health | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Peking University People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Invasive Fungal Infections | 18 |
| Mycoses | 3 |
| Neutropenia | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Candidiasis, Chronic Mucocutaneous | 1 |
| Candidiasis, Invasive | 1 |
| Graft vs Host Disease | 1 |
| Hematologic Neoplasms | 1 |
| Invasive Pulmonary Aspergillosis | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.